What is Krystal Biotech, Inc.'s gross unrealized gains?

Krystal Biotech, Inc. (KRYS) reported gross unrealized gains of $290K in Q1 2026.

How has Krystal Biotech, Inc.'s gross unrealized gains changed year-over-year?

Krystal Biotech, Inc.'s gross unrealized gains decreased by 66.5% year-over-year, from $866K to $290K.

What is the long-term trend for Krystal Biotech, Inc.'s gross unrealized gains?

Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s gross unrealized gains has grown at a 179.3% compound annual growth rate (CAGR), from $7K to $1.19M.

Krystal Biotech, Inc. KRYS Gross Unrealized Gains

Gross Unrealized Gains at other companies

BridgeBio PharmaBBIO

——

Gilead SciencesGILD

——

BiogenBIIB

——

Merck & Co.MRK

——

BioMarin PharmaceuticalsBMRN

——

Regeneron PharmaceuticalsREGN

——

Other financials

Income statement

See full

Revenue$116.4M+31.9%

Operating income$53.7M+48.1%

Net income$55.9M+56.5%

EPS (diluted)$1.83+52.5%

Balance sheet

See full

Cash & equivalents$501.3M+62.4%

Total debt$9.1M-5.7%

Total equity$1.3B+29.7%

Total assets$1.4B+30.0%

Cash flow

See full

Operating cash flow$80.4M+160%

CapEx$7.1M+15.2%

Free cash flow$73.2M+196%

Valuation

See full

Market cap$10.26B+45.4%

Enterprise value$9.77B+44.2%

P/E45.6×-11.3×

P/S24.6×+3.4×

Profitability

See full

Operating margin42.8%+10.2pp

Net margin53.9%+16.7pp

FCF margin56.9%+16.5pp

Returns & leverage

See full

Return on equity19.9%+6.0pp

Debt / equity0×0.0×

Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s gross unrealized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s gross unrealized gains?: Krystal Biotech, Inc. (KRYS) reported gross unrealized gains of $290K in Q1 2026.
How has Krystal Biotech, Inc.'s gross unrealized gains changed year-over-year?: Krystal Biotech, Inc.'s gross unrealized gains decreased by 66.5% year-over-year, from $866K to $290K.
What is the long-term trend for Krystal Biotech, Inc.'s gross unrealized gains?: Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s gross unrealized gains has grown at a 179.3% compound annual growth rate (CAGR), from $7K to $1.19M.